2026 NPPES data Pediatric Hematology & Oncology Physician NPI 1134279177 MD
Verify on CMS →

RAMAMOORTHY NAGASUBRAMANIAN, MD

Pediatric Hematology & Oncology Physician in PALO ALTO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
35
Medicare Part D claims · Pediatric Hematology & Oncology Physician avg: 92
Generic prescribing
60%
generic claims · 40% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

RAMAMOORTHY NAGASUBRAMANIAN, MD filed 35 Medicare Part D claims in 2023 as a Pediatric Hematology & Oncology Physician in PALO ALTO, California, prescribing 60% generic.

35
Part D claims, 2023
60%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RAMAMOORTHY NAGASUBRAMANIAN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

35 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

RAMAMOORTHY NAGASUBRAMANIAN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RAMAMOORTHY NAGASUBRAMANIAN, MD?

Quality data not reported

NPI registry status

Active

Issued 01/11/2007

NPI 1134279177

Primary specialty

Pediatric Hematology & Oncology Physician

Niche

2,568 US NPIs in this specialty

Medicare Part D claims

35 62% vs specialty avg

2023 prescription claims

Specialty avg: 92

Specialty distribution in California

How Pediatric Hematology & Oncology Physician compares to other specialties among California providers

California providers

Pediatric Hematology & Oncology Physician share within California

1. Pediatric Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Hematology & Oncology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pediatric Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pediatric Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Pediatric Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pediatric Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RAMAMOORTHY NAGASUBRAMANIAN, MD appears in the CMS NPPES registry as a Pediatric Hematology & Oncology Physician provider holding MD credentials at 725 WELCH RD, PALO ALTO, CA, 94304, with a listed phone of (650) 497-8000. NPI 1134279177 was issued on 01/11/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NAGASUBRAMANIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 35 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $44K in drug spend, split 40% brand-name and 60% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pediatric Hematology & Oncology Physician is a narrow specialty nationwide, with 2,568 enrolled providers across 52 states and an average of 92 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

725 WELCH RD
PALO ALTO, CA 94304

Provider Details

NPI 1134279177
Specialty Pediatric Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 01/11/2007

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to RAMAMOORTHY NAGASUBRAMANIAN, MD. To verify RAMAMOORTHY NAGASUBRAMANIAN, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

RAMAMOORTHY NAGASUBRAMANIAN, MD — brand share 40.0%
Specialty average (est.)

40% brand-name claims vs 60% generic, on 35 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

35
Total Claims
$44K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
63
Total Day Supply
1,707
Brand vs Generic
40% brand / 60% generic
Brand Drug Cost
$44K
Generic Drug Cost
$206

Patient Demographics

Average Patient Age
42.0 years
Avg HCC Risk Score
3.27

Pediatric Hematology & Oncology Physician Overview

How RAMAMOORTHY NAGASUBRAMANIAN, MD fits within the Pediatric Hematology & Oncology Physician landscape nationally.

2,568
Pediatric Hematology & Oncology Physician Providers in US
52
States with Pediatric Hematology & Oncology Physician
92
Avg Claims per Provider

RAMAMOORTHY NAGASUBRAMANIAN, MD's 35 claims are below the specialty average of 92.

Nearby Pediatric Hematology & Oncology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as NAGASUBRAMANIAN.

Compare Pediatric Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RAMAMOORTHY NAGASUBRAMANIAN, MD's specialty?
RAMAMOORTHY NAGASUBRAMANIAN, MD specializes in Pediatric Hematology & Oncology Physician and practices in PALO ALTO, California. Credentials: MD.
How much does RAMAMOORTHY NAGASUBRAMANIAN, MD prescribe under Medicare Part D?
In 2023, RAMAMOORTHY NAGASUBRAMANIAN, MD wrote 35 Medicare Part D claims totaling $44K in drug costs for N/A beneficiaries.
Where is RAMAMOORTHY NAGASUBRAMANIAN, MD located?
RAMAMOORTHY NAGASUBRAMANIAN, MD is located at 725 WELCH RD, PALO ALTO, CA, 94304. Phone: (650) 497-8000.
What is RAMAMOORTHY NAGASUBRAMANIAN, MD's NPI number?
RAMAMOORTHY NAGASUBRAMANIAN, MD's National Provider Identifier (NPI) is 1134279177, issued on 01/11/2007.
Does RAMAMOORTHY NAGASUBRAMANIAN, MD prescribe more brand-name or generic drugs?
RAMAMOORTHY NAGASUBRAMANIAN, MD's prescribing is 40% brand-name and 60% generic drugs by claim count, with $44K in brand drug costs.
How many Pediatric Hematology & Oncology Physician providers are there in the US?
There are 2,568 Pediatric Hematology & Oncology Physician providers across 52 states in the US. The average Pediatric Hematology & Oncology Physician provider writes 92 Medicare Part D claims per year.
Does RAMAMOORTHY NAGASUBRAMANIAN, MD accept Medicare?
RAMAMOORTHY NAGASUBRAMANIAN, MD appears in CMS Medicare data with 35 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RAMAMOORTHY NAGASUBRAMANIAN, MD's credentials?
RAMAMOORTHY NAGASUBRAMANIAN, MD's NPI is 1134279177 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology